Jia Liang Kwek1, Konstadina Griva2, Navreen Kaur3, Kay Yuan Chong3, Zi Yang Chua2, Gim Hong Andy Sim4, Li Choo Ng5, Pay Wen Yong6, Yu-Tzu Tung7, Lydia Wei Wei Lim8, Su Hooi Teo8, Jason Chon Jun Choo8, Marjorie Wai Yin Foo8, Tazeen Hasan Jafar9. 1. Department of Renal Medicine, Singapore General Hospital, Academia Level 3, 20 College Road, Singapore, 169856, Singapore. kwek.jia.liang@singhealth.com.sg. 2. Health Psychology/Behavioural Medicine, Lee Kong Chian School of Medicine, Nanyang Technological University, Singapore, Singapore. 3. Division of Medicine, Singapore General Hospital, Singapore, Singapore. 4. Department of Medical Social Services, Singapore General Hospital, Singapore, Singapore. 5. Nursing Division, Singapore General Hospital, Singapore, Singapore. 6. Department of Dietetics, Singapore General Hospital, Singapore, Singapore. 7. Department of Pharmacy, Singapore General Hospital, Singapore, Singapore. 8. Department of Renal Medicine, Singapore General Hospital, Academia Level 3, 20 College Road, Singapore, 169856, Singapore. 9. Duke-NUS Medical School, Health Services and Systems Research, Singapore, Singapore.
Abstract
OBJECTIVE: This study aimed at determining the feasibility of conducting a large-scale pragmatic effectiveness study on the implementation of multidisciplinary care (MDC) program for patients with advanced chronic kidney disease (CKD). METHODS: This is a single-arm pre-post intervention design pilot study over 12 months. Participants with an estimated glomerular filtration rate (eGFR) between 11 and 20 ml/min/1.73m2 were screened and recruited at the initial MDC clinic visit and followed for 12 months. Clinical parameters, KDQOL™-36, questionnaires, and interviews were collected, administered, and analysed for enrolment and completion rates, baseline characteristics, implementation fidelity, adherence to CKD interventions, eGFR decline, CKD complications, health-related quality of life, and participants' acceptability of the program. RESULTS: The study enrolment and completion rates were 43.1% (50/116 screened) and 66.0% (33/50 recruited) respectively. The participants had a mean age of 68.5 years (SD9.0) and a mean eGFR of 15.4 ml/min/1.73m2(3.2). After 12 months of MDC program, there was increased adherence to CKD interventions (difference - 0.6(1.0), 95%CI - 1.1, - 0.1, p = 0.02). There was good participants' acceptability of the program with participants being more satisfied with the waiting time and having a better understanding of kidney failure after attending the program. No difference in the eGFR decline noted (difference 0.0 ml/min/1.73m2(5.3), 95%CI - 1.9, 1.9, p = 1.00). CONCLUSION: Our pilot data suggest increased adherence to CKD interventions and good acceptability to MDC program, albeit no difference in eGFR decline probably because of the small sample size. However, reasons for overall low enrolment and completion rates need to be explored and addressed while designing a future large-scale randomised controlled trial.
OBJECTIVE: This study aimed at determining the feasibility of conducting a large-scale pragmatic effectiveness study on the implementation of multidisciplinary care (MDC) program for patients with advanced chronic kidney disease (CKD). METHODS: This is a single-arm pre-post intervention design pilot study over 12 months. Participants with an estimated glomerular filtration rate (eGFR) between 11 and 20 ml/min/1.73m2 were screened and recruited at the initial MDC clinic visit and followed for 12 months. Clinical parameters, KDQOL™-36, questionnaires, and interviews were collected, administered, and analysed for enrolment and completion rates, baseline characteristics, implementation fidelity, adherence to CKD interventions, eGFR decline, CKD complications, health-related quality of life, and participants' acceptability of the program. RESULTS: The study enrolment and completion rates were 43.1% (50/116 screened) and 66.0% (33/50 recruited) respectively. The participants had a mean age of 68.5 years (SD9.0) and a mean eGFR of 15.4 ml/min/1.73m2(3.2). After 12 months of MDC program, there was increased adherence to CKD interventions (difference - 0.6(1.0), 95%CI - 1.1, - 0.1, p = 0.02). There was good participants' acceptability of the program with participants being more satisfied with the waiting time and having a better understanding of kidney failure after attending the program. No difference in the eGFR decline noted (difference 0.0 ml/min/1.73m2(5.3), 95%CI - 1.9, 1.9, p = 1.00). CONCLUSION: Our pilot data suggest increased adherence to CKD interventions and good acceptability to MDC program, albeit no difference in eGFR decline probably because of the small sample size. However, reasons for overall low enrolment and completion rates need to be explored and addressed while designing a future large-scale randomised controlled trial.
Authors: Elizabeth A Bayliss; Bharati Bhardwaja; Colleen Ross; Arne Beck; Diane M Lanese Journal: Clin J Am Soc Nephrol Date: 2011-01-27 Impact factor: 8.237
Authors: Brendan J Barrett; Amit X Garg; Ron Goeree; Adeera Levin; Anita Molzahn; Claudio Rigatto; Joel Singer; George Soltys; Steven Soroka; Dieter Ayers; Patrick S Parfrey Journal: Clin J Am Soc Nephrol Date: 2011-05-26 Impact factor: 8.237
Authors: Mieke J Peeters; Arjan D van Zuilen; Jan A J G van den Brand; Michiel L Bots; Marjolijn van Buren; Marc A G J Ten Dam; Karin A H Kaasjager; Gerry Ligtenberg; Yvo W J Sijpkens; Henk E Sluiter; Peter J G van de Ven; Gerald Vervoort; Louis-Jean Vleming; Peter J Blankestijn; Jack F M Wetzels Journal: J Am Soc Nephrol Date: 2013-10-24 Impact factor: 10.121
Authors: J D Kopple; T Greene; W C Chumlea; D Hollinger; B J Maroni; D Merrill; L K Scherch; G Schulman; S R Wang; G S Zimmer Journal: Kidney Int Date: 2000-04 Impact factor: 10.612
Authors: Deborah J Bowen; Matthew Kreuter; Bonnie Spring; Ludmila Cofta-Woerpel; Laura Linnan; Diane Weiner; Suzanne Bakken; Cecilia Patrick Kaplan; Linda Squiers; Cecilia Fabrizio; Maria Fernandez Journal: Am J Prev Med Date: 2009-05 Impact factor: 5.043
Authors: Erin J Howden; Rodel Leano; William Petchey; Jeff S Coombes; Nicole M Isbel; Thomas H Marwick Journal: Clin J Am Soc Nephrol Date: 2013-08-22 Impact factor: 8.237
Authors: Sandra M Eldridge; Claire L Chan; Michael J Campbell; Christine M Bond; Sally Hopewell; Lehana Thabane; Gillian A Lancaster Journal: BMJ Date: 2016-10-24